secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pelthos Therapeutics Inc. (PTHS)
CIK:        0001919246
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001753926-24-001376
Event type: other_material
Sentiment:  positive
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chromocell authorizes $250K stock repurchase plan; up to ~23% of non-affiliate float
--------------------------------------------------------------------------------

- Authorized repurchase of up to $250,000 of common stock, representing ~23% of non-affiliate float.
- Repurchases may occur via open market or private transactions through Dec 31, 2024.
- CEO states stock price does not reflect progress in developing non-opioid pain treatments.
- Plan does not obligate company to repurchase any shares; may be modified or terminated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1919246/000175392624001376/0001753926-24-001376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1919246/000175392624001376/g084379_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-24-001376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer